BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 26653538)

  • 1. Reproducibility of Differential Proteomic Technologies in CPTAC Fractionated Xenografts.
    Tabb DL; Wang X; Carr SA; Clauser KR; Mertins P; Chambers MC; Holman JD; Wang J; Zhang B; Zimmerman LJ; Chen X; Gunawardena HP; Davies SR; Ellis MJ; Li S; Townsend RR; Boja ES; Ketchum KA; Kinsinger CR; Mesri M; Rodriguez H; Liu T; Kim S; McDermott JE; Payne SH; Petyuk VA; Rodland KD; Smith RD; Yang F; Chan DW; Zhang B; Zhang H; Zhang Z; Zhou JY; Liebler DC
    J Proteome Res; 2016 Mar; 15(3):691-706. PubMed ID: 26653538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality Assessments of Long-Term Quantitative Proteomic Analysis of Breast Cancer Xenograft Tissues.
    Zhou JY; Chen L; Zhang B; Tian Y; Liu T; Thomas SN; Chen L; Schnaubelt M; Boja E; Hiltke T; Kinsinger CR; Rodriguez H; Davies SR; Li S; Snider JE; Erdmann-Gilmore P; Tabb DL; Townsend RR; Ellis MJ; Rodland KD; Smith RD; Carr SA; Zhang Z; Chan DW; Zhang H
    J Proteome Res; 2017 Dec; 16(12):4523-4530. PubMed ID: 29124938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Description of the Clinical Proteomic Tumor Analysis Consortium (CPTAC) Common Data Analysis Pipeline.
    Rudnick PA; Markey SP; Roth J; Mirokhin Y; Yan X; Tchekhovskoi DV; Edwards NJ; Thangudu RR; Ketchum KA; Kinsinger CR; Mesri M; Rodriguez H; Stein SE
    J Proteome Res; 2016 Mar; 15(3):1023-32. PubMed ID: 26860878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABRF Proteome Informatics Research Group (iPRG) 2015 Study: Detection of Differentially Abundant Proteins in Label-Free Quantitative LC-MS/MS Experiments.
    Choi M; Eren-Dogu ZF; Colangelo C; Cottrell J; Hoopmann MR; Kapp EA; Kim S; Lam H; Neubert TA; Palmblad M; Phinney BS; Weintraub ST; MacLean B; Vitek O
    J Proteome Res; 2017 Feb; 16(2):945-957. PubMed ID: 27990823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multi-model statistical approach for proteomic spectral count quantitation.
    Branson OE; Freitas MA
    J Proteomics; 2016 Jul; 144():23-32. PubMed ID: 27260494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Analysis of Label-Free and 8-Plex iTRAQ Approach for Quantitative Tissue Proteomic Analysis.
    Latosinska A; Vougas K; Makridakis M; Klein J; Mullen W; Abbas M; Stravodimos K; Katafigiotis I; Merseburger AS; Zoidakis J; Mischak H; Vlahou A; Jankowski V
    PLoS One; 2015; 10(9):e0137048. PubMed ID: 26331617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental Null Method to Guide the Development of Technical Procedures and to Control False-Positive Discovery in Quantitative Proteomics.
    Shen X; Hu Q; Li J; Wang J; Qu J
    J Proteome Res; 2015 Oct; 14(10):4147-57. PubMed ID: 26051676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QC metrics from CPTAC raw LC-MS/MS data interpreted through multivariate statistics.
    Wang X; Chambers MC; Vega-Montoto LJ; Bunk DM; Stein SE; Tabb DL
    Anal Chem; 2014 Mar; 86(5):2497-509. PubMed ID: 24494671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical Assessment of QC Metrics on Raw LC-MS/MS Data.
    Wang X
    Methods Mol Biol; 2017; 1550():325-337. PubMed ID: 28188539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive comparison of iTRAQ and label-free LC-based quantitative proteomics approaches using two Chlamydomonas reinhardtii strains of interest for biofuels engineering.
    Wang H; Alvarez S; Hicks LM
    J Proteome Res; 2012 Jan; 11(1):487-501. PubMed ID: 22059437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
    Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
    J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeatability and reproducibility in proteomic identifications by liquid chromatography-tandem mass spectrometry.
    Tabb DL; Vega-Montoto L; Rudnick PA; Variyath AM; Ham AJ; Bunk DM; Kilpatrick LE; Billheimer DD; Blackman RK; Cardasis HL; Carr SA; Clauser KR; Jaffe JD; Kowalski KA; Neubert TA; Regnier FE; Schilling B; Tegeler TJ; Wang M; Wang P; Whiteaker JR; Zimmerman LJ; Fisher SJ; Gibson BW; Kinsinger CR; Mesri M; Rodriguez H; Stein SE; Tempst P; Paulovich AG; Liebler DC; Spiegelman C
    J Proteome Res; 2010 Feb; 9(2):761-76. PubMed ID: 19921851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CPTAC Data Portal: A Resource for Cancer Proteomics Research.
    Edwards NJ; Oberti M; Thangudu RR; Cai S; McGarvey PB; Jacob S; Madhavan S; Ketchum KA
    J Proteome Res; 2015 Jun; 14(6):2707-13. PubMed ID: 25873244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LC-MS
    Souza GHMF; Guest PC; Martins-de-Souza D
    Methods Mol Biol; 2017; 1546():57-73. PubMed ID: 27896757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of statistical methods used for detecting differential expression in label-free mass spectrometry proteomics.
    Langley SR; Mayr M
    J Proteomics; 2015 Nov; 129():83-92. PubMed ID: 26193490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative label-free mass spectrometry using contralateral and adjacent breast tissues reveal differentially expressed proteins and their predicted impacts on pathways and cellular functions in breast cancer.
    Gomig THB; Cavalli IJ; Souza RLR; Vieira E; Lucena ACR; Batista M; Machado KC; Marchini FK; Marchi FA; Lima RS; de Andrade Urban C; Cavalli LR; Ribeiro EMSF
    J Proteomics; 2019 May; 199():1-14. PubMed ID: 30772490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting the iTRAQ Data Analysis.
    Aggarwal S; Yadav AK
    Methods Mol Biol; 2016; 1362():277-91. PubMed ID: 26519184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated Bottom-Up and Top-Down Proteomics of Patient-Derived Breast Tumor Xenografts.
    Ntai I; LeDuc RD; Fellers RT; Erdmann-Gilmore P; Davies SR; Rumsey J; Early BP; Thomas PM; Li S; Compton PD; Ellis MJ; Ruggles KV; Fenyö D; Boja ES; Rodriguez H; Townsend RR; Kelleher NL
    Mol Cell Proteomics; 2016 Jan; 15(1):45-56. PubMed ID: 26503891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A proteomics performance standard to support measurement quality in proteomics.
    Beasley-Green A; Bunk D; Rudnick P; Kilpatrick L; Phinney K
    Proteomics; 2012 Apr; 12(7):923-31. PubMed ID: 22522798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tools for monitoring system suitability in LC MS/MS centric proteomic experiments.
    Bereman MS
    Proteomics; 2015 Mar; 15(5-6):891-902. PubMed ID: 25327420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.